Log in to save to my catalogue

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1728290604

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Tiacci, Falini, and colleagues discovered
BRAF
mutations in nearly all patients with hairy-cell leukemia. Now, their group, along with U.S. investigators, has found response rates of 90% or higher among patients treated with the BRAF inhibitor vemurafenib.
Hairy-cell leukemia is a chronic mature B-cell cancer with unique clinicopathologic...

Alternative Titles

Full title

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1728290604

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1728290604

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1506583

How to access this item